Picture of Liminal BioSciences logo

LMNL — Liminal BioSciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Brief: Liminal Biosciences Inc - Plans To Divest Its Remaining Non-Core Assets, To Further Extend Runway

Jan 6 (Reuters) - Liminal BioSciences Inc  LMNL.O :
    * LIMINAL BIOSCIENCES INC - PLANS TO DIVEST ITS REMAINING
NON-CORE
ASSETS, TO FURTHER EXTEND RUNWAY
    * LIMINAL BIOSCIENCES INC - OXER1 ANTAGONIST DEVELOPMENT
PROGRAM
PROGRESSING TO IDENTIFICATION OF LEAD PRECLINICAL DRUG CANDIDATE
IN H1 2023
    * LIMINAL BIOSCIENCES INC - CLOSED DECEMBER 2022 WITH JUST
OVER
CAD 37 MILLION CASH ON HAND, EXPECTING TO PROVIDE A RUNWAY INTO
EARLY 2024

Source text for Eikon:  ID:nCNWHHFX3a 
Further company coverage:  LMNL.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Liminal BioSciences

See all news